半乳凝素-9抑制胶质瘤细胞增殖及迁移
Galectin-9 inhibits proliferation and migration of glioma cells

DOI: 10.6040/j.issn.1671-7554.0.2014.666

Keywords: 胶质瘤,迁移,半乳凝素-9,增殖,
Proliferation,Migration,Glioma,Galectin-9

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Hirashima M, Kashio Y, Nishi N, et al. Galectin-9 in physiological and pathological conditions[J]. Glycoconjugate Journal, 2004, 19(7-9):593-600.
[2]	Nobumoto A, Nagahara K, Oomizu S, et al. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices[J]. Glycobiology, 2008, 18(9):735-744.
[3]	Matsumoto R, Matsumoto H, Seki M, et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes[J]. J Biol Chem, 1998, 273(27):16976-16984.
[4]	Miyanishi N, Nishi N, Abe H, et al. Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family[J]. Glycobiology, 2007, 17(4):423-432.
[5]	Jiang J, Jin MS, Kong F, et al. Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer[J]. PLoS One, 2013, 8(12):e81799. doi:10.1371/journal.pone.0081799. eCollection 2013.
[6]	Yoshida H, Imaizumi T, Kumagai M, et al. Interleukin-1beta stimulates galectin-9 expression in human astrocytes[J]. Neuroreport, 2001, 12(17):3755-3758.
[7]	Kobayashi T, Kuroda J, Ashihara E, et al. Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways[J]. Leukemia, 2010, 24(4):843-850.
[8]	郭素平, 马军, 唐芙爱, 等. 食管鳞状细胞癌组织中Galectin-9和MMP-2蛋白的表达及与预后的关系[J]. 郑州大学学报:医学版, 2012, 47(6):749-752. GUO Suping, MA Jun, TANG Fuai, et al. Relationship between prognosis and expressions of Galectin-9 and MMP-2 in esophageal squamous cell carcinoma tissue[J]. Journal of Zhengzhou University: Medical Sciences, 2012, 47(6):749-752.
[9]	Lahm H, André S, Hoeflich A, et al. Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by PT-PCR and its implications for diagnostic and therapeutic procedures[J]. J Cancer Res Clin Oncol, 2001, 127(6):375-386.
[10]	Matsumoto R, Matsumoto H, Seki M, et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes[J]. J Biol Chem, 1998, 273(27):16976-16984.
[11]	Ishikawa A, Imaizumi T, Yoshida H, et al. Double-stranded RNA enhances the expression of galectin-9 in vascular endothelial cells[J]. Immunol Cell Biol, 2004, 82(4):410-414.
[12]	Zhang ZY, Dong JH, Chen YW, et al. Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma[J]. Asian Pacific J Cancer Prev, 2012, 13(6):2503-2509.
[13]	顾长江, 吴寒盛, 陈毅, 等. 半乳凝素9在肝细胞肝癌患者中的表达及其与预后的关系[J]. 中华医学杂志, 2013, 93(26):2025-2028. GU Changjiang, WU Hansheng, CHEN Yi, et al. Expression and prognostic value of galectin-9 in hepatocellular carcinoma patients[J]. National Medical Journal of China, 2013, 93(26):2025-2028.
[14]	Steelman AJ, Smith R 3rd, Welsh CJ, et al. Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis[J]. J Biol Chem, 2013, 288(33):23776-23787.
[15]	Wiersma VR, Bruyn M, Ginkel RJ, et al. The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells[J]. Journal of Investigative Dermatology, 2012, 132(9):2302-2305.
[16]	Irie A, Yamauchi A, Kontani K, et al. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer[J]. Clin Cancer Res, 2005, 11(8):2962-2968.

Full-Text